Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report

BACKGROUND: T cell-mediated eosinophilia is associated with numerous conditions—including atopic dermatitis, food allergies, and asthma—collectively known as the “atopic march.” Benralizumab is a recombinant, humanized, afucosylated monoclonal antibody directed against the ⍺ chain of the eosinophil...

Descripción completa

Detalles Bibliográficos
Autor principal: Pham, David N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936422/
https://www.ncbi.nlm.nih.gov/pubmed/33673870
http://dx.doi.org/10.1186/s13256-021-02663-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936422/
https://www.ncbi.nlm.nih.gov/pubmed/33673870
http://dx.doi.org/10.1186/s13256-021-02663-2

Ejemplares similares